You, Hyun published the artcileDesign, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents, Computed Properties of 116228-41-2, the main research area is benzoylpeperidinylbutylarylacrylamide preparation NAmPRTase inhibitory anticancer crystal XRD.
NAmPRTase (PBEF/Visfatin) plays a pivotal role in the salvage pathway of NAD+ biosynthesis. NAmPRTase has been an attractive target for anti-cancer agents that induce apoptosis of tumor cells via a declining plasma NAD+ level. In this report, a series of structural analogs of FK866 I, a known NAmPRTase inhibitor, was synthesized and tested for inhibitory activities against the proliferation of cancer cells and human NAmPRTase. Among them, compound II showed similar anti-cancer and enzyme inhibitory activities to compound I. Further investigation of compound II with X-ray anal. revealed a co-crystal structure in complex with human NAmPRTase, suggesting that Asp219 in the active site of the enzyme could contribute to an addnl. interaction with the pyrrole nitrogen of compound II.
European Journal of Medicinal Chemistry published new progress about Amidation. 116228-41-2 belongs to class pyrazoles-derivatives, name is 4-Bromo-1-tosyl-1H-pyrazole, and the molecular formula is C10H9BrN2O2S, Computed Properties of 116228-41-2.
Referemce:
Pyrazole – Wikipedia,
Pyrazoles – an overview | ScienceDirect Topics